A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder

References

• Alexander BK, Hadaway PF. 1982. Opiate addiction: the case for an adaptive orientation. Psychol Bull. 92:367.
   PubMed Web of Science ®Google Scholar
• Bart G. 2012. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 31:207–225.
   PubMed Web of Science ®Google Scholar
• Bartz JA, Zaki J, Bolger N, Ochsner KN. 2011. Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci. 15:301–309.
   PubMed Web of Science ®Google Scholar
• Bentzley BS, Jhou TC, Aston-Jones G. 2014. Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rate. Proc Natl Acad Sci USA. 111:11822–11827.
   PubMed Web of Science ®Google Scholar
• Best D, Beckwith M, Haslam C, Haslam SA, Jetten J, Mawson E, Lubman DI. 2016. Overcoming alcohol and other drug addiction as a process of social identity transition: the social identity model of recovery (SIMOR). Addict Res Theory. 24:111–123.
   Web of Science ®Google Scholar
• Bisagno V, Cadet JL. 2014. Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin. Behav Pharmacol. 25:445–457.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. 2007. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 87:297–302.
   PubMed Web of Science ®Google Scholar
• Cardoso C, Kingdon D, Ellenbogen MA. 2014. A meta-analytic review of the impact of intranasal oxytocin administration on cortisol concentrations during laboratory tasks: moderation by method and mental health. Psychoneuroendocrinology. 49:161–170.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FH. 1994. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 51:177–187.
   PubMed Web of Science ®Google Scholar
• Carson DS, Guastella AJ, Taylor ER, McGregor IS. 2013. A brief history of oxytocin and its role in modulating psychostimulant effects. J Psychopharmacol. 27:231–247.
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. 1989. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 261:561–565.
   PubMed Web of Science ®Google Scholar
• de la Fuente L, Molist G, Espelt A, Barrio G, Guitart A, Bravo MJ, Brugal MT. 2014. Mortality risk factors and excess mortality in a cohort of cocaine users admitted to drug treatment in Spain. J Subst Abuse Treat. 46:219–226.
   PubMed Web of Science ®Google Scholar
• Declerck CH, Boone C, Kiyonari T. 2010. Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Horm Behav. 57:368–374.
   PubMed Web of Science ®Google Scholar
• Everitt BJ. 2014. Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction. Eur J Neurosci. 40:2163–2182.
   PubMed Web of Science ®Google Scholar
• Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA. 2000. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 157:1789–1798.
   PubMed Web of Science ®Google Scholar
• Greenwald AG, Nosek BA, Banaji MR. 2003. Understanding and using the implicit association test: I. An improved scoring algorithm. J Personal Soc Psychol. 85:197.
   PubMed Web of Science ®Google Scholar
• Grillon C, Krimsky M, Charney D, Vytal K, Ernst M, Cornwell B. 2013. Oxytocin increases anxiety to unpredictable threat. Mol Psychiatry. 18:958.
   PubMed Web of Science ®Google Scholar
• Guastella A, Hickie IB, McGuinness MM, Otis M WE, Disinger HM, Chan HK, Chen TF, Banati RB. 2013. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology. 38:612–625.
   PubMed Web of Science ®Google Scholar
• Heinz AJ, Epstein DH, Schroeder JR, Singleton EG, Heishman SJ, Preston KL. 2006. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J Substance Abuse Treat. 31:355–364.
   PubMed Web of Science ®Google Scholar
• Hofmann SG, Fang A, Brager DN. 2015. Effect of intranasal oxytocin administration on psychiatric symptoms: a meta-analysis of placebo-controlled studies. Psychiatr Res. 228:708–714.
   PubMed Web of Science ®Google Scholar
• Insel T. 2003. Is social attachment an addictive disorder? Physiol Behav. 79:351–357.
   PubMed Web of Science ®Google Scholar
• Lan K-C, Chang AC, Liu S-H, Ho IK, Lin-Shiau S-Y. 2009. Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice. J Neurochem. 109:382–392.
   PubMed Web of Science ®Google Scholar
• Lee MR, Glassman M, King-Casas B, Kelly DL, Stein EA, Schroeder J, Salmeron BJ. 2014. Complexity of oxytocin’s effects in a chronic cocaine dependent population. Eur Neuropsychopharmacol. 24:1483–1491.
   PubMed Web of Science ®Google Scholar
• Lieberwirth C, Wang Z. 2014. Social bonding: regulation by neuropeptides. Front Neurosci. 8:171.
   PubMed Web of Science ®Google Scholar
• Lin SH, Lee LT, Tsai HC, Chen WT, Lee IH, LU RB, Chen PS, Yang YK. 2015. Association between blood level of plasma oxytocin and novelty seeking among methadone-maintained heroin users. Neuropsychobiology. 71:65–69.
   PubMed Web of Science ®Google Scholar
• Lynch KL, Dominy SS, Graf J, Kral AH. 2011. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 35:176–178.
   PubMed Web of Science ®Google Scholar
• MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ. 2011. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 36:1114–1126.
   PubMed Web of Science ®Google Scholar
• Mantsch JR, Baker DA, Funk D, Lê AD, Shaham Y. 2016. Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology. 41:335–356.
   PubMed Web of Science ®Google Scholar
• Marhe R, Waters AJ, van de Wetering BJ, Franken IH. 2013. Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study. J Consult Clin Psychol. 81:1–12.
   PubMed Web of Science ®Google Scholar
• McRae-Clark AL, Baker NL, Moran-Santa Maria M, Brady KT. 2013. Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology. 228:623–631.
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. 2011. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 12:524–538.
   PubMed Web of Science ®Google Scholar
• Morales-Rivera A, Hernández-Burgos MM, Martínez-Rivera A, Pérez-Colón J, Rivera R, Montalvo J, Rodríguez-Borrero E, Maldonado-Vlaar CS. 2014. Anxiolytic effects of oxytocin in cue-induced cocaine seeking behavior in rats. Psychopharmacology. 231:4145–4155.
   PubMed Web of Science ®Google Scholar
• Myers AJ, Williams L, Gatt JM, McAuley-Clark EZ, Dobson-Stone C, Schofield PR, Nemeroff CB. 2014. Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress. J Psychiatr Res. 59:93–100.
   PubMed Web of Science ®Google Scholar
• Pedersen CA, Smedley KL, Leserman J, Jarskog LF, Rau SW, Kampov‐Polevoi A, Casey RL, Fender T, Garbutt JC. 2013. Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcohol Clin Exp Res. 37:484–489.
   PubMed Web of Science ®Google Scholar
• Preston KL, Sullivan JT, Strain EC, Bigelow GE. 1996. Enhancement of cocaine’s abuse liability in methadone maintenance patients. Psychopharmacology. 123:15–25.
   PubMed Web of Science ®Google Scholar
• Robins LN, Helzer JE, Hesselbrock M, Wish E. 2010. Vietnam veterans three years after Vietnam: how our study changed our view of heroin. Am J Addict. 19:203–211.
   PubMed Web of Science ®Google Scholar
• Rooke SE, Hine DW, Thorsteinsson EB. 2008. Implicit cognition and substance use: a meta-analysis. Addict Behav. 33:1314–1328.
   PubMed Web of Science ®Google Scholar
• Rowan-Szal GA, Joe GW, Simpson DD. 2000. Treatment retention of crack and cocaine users in a national sample of long term residential clients. Addict Res Theory. 8:51–64.
   Web of Science ®Google Scholar
• Sarnyai Z, Kovács GL. 2014. Oxytocin in learning and addiction: from early discoveries to the present. Pharmacol Biochem Behav. 119:3–9.
   PubMed Web of Science ®Google Scholar
• Siqueland L, Crits‐Christoph P, Gallop R, Barber JP, Griffin ML, Thase ME, Daley D, Frank A, Gastfriend DR, Blaine J, et al. 2002. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict. 11:24–40.
   PubMed Web of Science ®Google Scholar
• Stauffer CS, Woolley JD. 2014. Can we bottle psychosocial treatments for addiction? The role of oxytocin. J Clin Psychiatry. 75:1028.
   PubMed Web of Science ®Google Scholar
• Thompson M, Callaghan P, Hunt G, Cornish J, McGregor I. 2007. A role for oxytocin and 5-HT 1A receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine (“ecstasy”). Neuroscience. 146:509–514.
   PubMed Web of Science ®Google Scholar
• Tops M, Koole SL, IJzerman H, Buisman-Pijlman FT. 2014. Why social attachment and oxytocin protect against addiction and stress: insights from the dynamics between ventral and dorsal corticostriatal systems. Pharmacol Biochem Behav. 119:39–48.
   PubMed Web of Science ®Google Scholar
• Weinstock J, Rash CJ, Petry NM. 2010. Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen? Psychol Addictive Behav. 24:282–291.
   PubMed Web of Science ®Google Scholar
• White WL, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL. 2014. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. J Psychoact Drugs. 46:114–122.
   PubMed Web of Science ®Google Scholar
• Zanos P, Georgiou P, Wright SR, Hourani SM, Kitchen I, Winsky-Sommerer R, Bailey A. 2014. The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology. 39:855–865.
   PubMed Web of Science ®Google Scholar